How to Use Myopia Profile
Getting the most out of Myopia Profile Welcome to the world’s largest and most popular multi-platform digital suite dedicated to
Getting started – choosing a treatment for fast myopia progressors
Myopia control is vital for children with fast myopia progression. What are the key risk factors for faster myopia progression? What clinical findings indicate a more proactive myopia management strategy may be required? This case describes risk factors and evidence-based treatment options for fast myopia progressors.
Which clinical tests are required for myopia management?
Which clinical tests are required for myopia management? Here we take you through the recommendations of the International Myopia Institute (IMI) Clinical Management Guidelines Report, with references to several more of the IMI Reports including the latest Volume in 2021. You have everything you need to get started – learn more here.
Is axial length regression possible?
Axial length typically increases in children, and myopia control aims to slow this excessive growth. Can axial length regression or reduction be possible in myopia control? In this case study, an 8-year-old appears to show a large reduction in axial length. We investigate possible causes and provide clinical guidance on measurement accuracy.
Is it really fast progressing myopia, or something else?
In this case, a 14-year-old was found to be far less myopic than their refraction and terrifyingly fast progression suggested, thanks to careful diagnosis. Learn what didn’t add up and how utilizing technology o measure the ocular components helped to solve the puzzling clinical case.
How to Use Axial Length Growth Charts
Growth charts are commonly used in childhood health and are easily understood by parents. When applied to myopia management, axial length growth charts can allow individualized decisions on treatment strategy and efficacy. What charts are available now and how can you use them in practice? Here we explain how to use axial length growth charts from initial diagnosis to treatment strategy and long term monitoring.
Exploring the limits of myopia control efficacy
Considering even emmetropic eyes elongate, what are the limits of myopia control efficacy? This novel analysis explores the absolute axial elongation of treated and untreated myopes in the MiSight 3-year clinical trial in comparison to previously published models of myopic and emmetropic eye growth. The results indicate a potential limit to the short-term percentage efficacy of myopia control treatments.
Enhancing Near Vision With MiSight 1 day
MiSight 1 day is a dual focus optical design. Does this affect children’s near vision? What can be done to manage any issues with near vision as noticed by wearers? Read more about expectations and adaptation.
Mastering MiSight 1 day
What can you expert in short-term fitting, vision, handling and comfort outcomes in children through to long term outcomes in myopia control, vision and ocular health? This article provides the scientific and clinical basis to get started and continue successfully fitting MiSight 1 day for myopic children.
Why MiSight 1 day is not a multifocal contact lens
MiSight 1 day is a dual focus contact lens – it’s not a multifocal as it does not provide an ‘add’ at near. When considering a first correction for a young myope, how should we prioritize both myopia correction and control? Read more in this case.
How can we set myopia control expectations?
When setting myopia control expectations both at outset and follow up, it is important to compare the child’s observed myopia progression to ‘average’, and to then judge the expected outcomes of treatment. Bringing their lifestyle, motivations and abilities into consideration is also important. Here we explore how to use resources in practice to set expectations and gauge success along the way.
